<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T21:02:20Z</responseDate>
  <request identifier="oai:figshare.com:article/34028937" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34028937</identifier>
        <datestamp>2026-09-30T03:44:17Z</datestamp>
        <setSpec>category_46</setSpec>
        <setSpec>portal_81</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Additional file 1 of Co-expression of non-signaling CARs enhances EGFRvIII-specific CAR T-cell cytotoxicity against head and neck squamous cell carcinoma</dc:title>
          <dc:creator>Kathleen Grueter (25140531)</dc:creator>
          <dc:creator>Nicole Sander (25140534)</dc:creator>
          <dc:creator>Luisa Coen (24362463)</dc:creator>
          <dc:creator>Saskia Hüsken (21616072)</dc:creator>
          <dc:creator>Eileen Kleinfelder (25140537)</dc:creator>
          <dc:creator>Corinna Haist (11715974)</dc:creator>
          <dc:creator>Franziska Blaeschke (12356629)</dc:creator>
          <dc:creator>Kathrin Scheckenbach (3944783)</dc:creator>
          <dc:creator>Cornelia Monzel (1553617)</dc:creator>
          <dc:creator>Helmut Hanenberg (140467)</dc:creator>
          <dc:creator>Constanze Wiek (140463)</dc:creator>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>HNSCC</dc:subject>
          <dc:subject>EGFRvIII</dc:subject>
          <dc:subject>CAR T-cell therapy</dc:subject>
          <dc:subject>Non-signaling CAR</dc:subject>
          <dc:subject>Tumor-specific antigen (TSA)</dc:subject>
          <dc:subject>Immunotherapy</dc:subject>
          <dc:subject>Antigen density</dc:subject>
          <dc:subject>Dual-epitope engagement</dc:subject>
          <dc:description>Supplementary Material 1.</dc:description>
          <dc:date>2026-09-29T05:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.6084/m9.figshare.34028937.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Additional_file_1_of_Co-expression_of_non-signaling_CARs_enhances_EGFRvIII-specific_CAR_T-cell_cytotoxicity_against_head_and_neck_squamous_cell_carcinoma/34028937</dc:relation>
          <dc:rights>CC BY</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
